Invitrogen™ ELISA human COX-2 kit

Ref.: BL-RE-091651Manufacturer ref.: EH125RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

COX-2 converts the arachidonate to prostaglandin H2 (PGH2), a step involved in prostanoid synthesis, including the production of inflammatory prostaglandins. The conversion of the arachidonate to prostaglandin H2 is a reaction in two...

Accession number
P35354
Dose range
1.2 to 300 ng/ml
Sensitivity of the dosage
1.2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

COX-2 converts the arachidonate to prostaglandin H2 (PGH2), a step involved in prostanoid synthesis, including the production of inflammatory prostaglandins. The conversion of the arachidonate to prostaglandin H2 is a reaction in two...

COX-2 converts the arachidonate to prostaglandin H2 (PGH2), a step involved in prostanoid synthesis, including the production of inflammatory prostaglandins. The conversion of l的arachidonate to prostaglandin H2 is a two-step reaction: a cyclooxygenase reaction (COX) that converts l的arachidonate to prostaglandin G2 (PGG2) and a peroxidase reaction in which PGG2 is reduced to prostaglandin H2 (PGH2). It is expressed constitutively in certain tissues under physiological conditions, such as the endothelium, kidney and brain, and is regulated upwards under pathological conditions, such as cancer and inflammation (unlike the PTGS1 isoenzyme, which is expressed ubiquitously). Increased regulation of COX-2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumour angiogenesis. In cancer cells, COX-2 is a key step in the production of prostaglandin E2 (PGE2), which plays an important role in the modulation of motility, proliferation and resistance to apoptosis. COX-2 is naturally inhibited by calcitriol (active form of vitamin D). Glucocorticoids chronically suppress PTGS2 gene activity in vivo in part by interfering with transcription initiation and elongation. COX-2 is a target of d-AINS such as the aspirin, which can reduce pain and swelling due to inflammation caused by COX-2.

Sensitivity

Sensitivity of dosage: 1.2 ng/ml.

Measurement range

Dose range: 1.2 to 300 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: COX2.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17797553
Specifications
Accession numberP35354
Dose range1.2 to 300 ng/ml
Sensitivity of the dosage1.2 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)5743
Gene symbol(s)PTGS2
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetCOX2
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Serum, 50 μl-Surnatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH125RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.